3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Sarcoma
15
Sarcoma, Ewing
10
Neuroblastoma
7
Rhabdomyosarcoma
6
Osteosarcoma
6
Gliosarcoma
6
Glioblastoma
6
Brain Neoplasms
6
Astrocytoma
6
Neuroectodermal Tumors, Primitive, Peripheral
5
Medulloblastoma
5
Central Nervous System Neoplasms
5
Glioma
4
Wilms Tumor
3
Sarcoma, Clear Cell
3
Rhabdoid Tumor
3
Recurrence
3
Desmoplastic Small Round Cell Tumor
3
Dendritic Cell Sarcoma, Interdigitating
3
Burkitt Lymphoma
3
Testicular Neoplasms
2
Retinoblastoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Optic Nerve Glioma
2
Oligodendroglioma
2
Myoepithelioma
2
Meningeal Carcinomatosis
2
Malignant mesenchymal tumor
2
Lymphoma
2
Interventions
Cyclophosphamide
4
Sirolimus
3
pembrolizumab
2
fludarabine
2
etoposide phosphate
2
Mesna
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Celecoxib
2
Busulfan
2
ripretinib
1
repotrectinib
1
pegylated granulocyte colony-stimulating factor
1
interferon gamma-1b
1
fludarabine phosphate
1
bintrafusp alfa protein, human
1
Vorinostat
1
Ursodeoxycholic Acid
1
Topotecan
1
Thrombopoietin
1
Thiotepa
1
Therapeutics
1
Tetrahydrouridine
1
Stem Cell Transplantation
1
Simvastatin
1
Radiotherapy, Image-Guided
1
Radiation
1
Psychiatric Rehabilitation
1
Plicamycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Topotecan
×
Sarcoma
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled